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†Department of Chemical and Biomolecular Engineering, and ‡Department of Chemistry, University of Houston, Houston, TexasABSTRACT In search of novel control parameters for the polymerization of sickle cell hemoglobin (HbS), the primary patho-
genic event of sickle cell anemia, we explore the role of free heme, which may be excessively released in sickle erythrocytes.
We show that the concentration of free heme in HbS solutions typically used in the laboratory is 0.02–0.04mole heme/mole HbS.
We show that dialysis of small molecules out of HbS solutions arrests HbS polymerization. The addition of 100–260 mM of free
heme to dialyzed HbS solutions leads to rates of nucleation and polymer fiber growth faster by two orders of magnitude than
before dialysis. Toward an understanding of the mechanism of nucleation enhancement by heme, we show that free heme at
a concentration of 66 mM increases by two orders of magnitude the volume of the metastable clusters of dense HbS liquid,
the locations where HbS polymer nuclei form. These results suggest that spikes of the free heme concentration in the erythro-
cytes of sickle cell anemia patients may be a significant factor in the complexity of the clinical manifestations of sickle cell
anemia. The prevention of free heme accumulation in the erythrocyte cytosol may be a novel avenue to sickle cell therapy.INTRODUCTIONThe polymerization of sickle cell hemoglobin (HbS) (1–3) is
the primary event (4,5) in the pathophysiology of sickle
cell anemia (6,7). The polymerization has been described
via a double-nucleation mechanism, an elaboration of the
nucleation-and-growth scenario typical of first-order phase
transitions, according to which homogeneous nucleation
of single fibers is followed by their growth and branching
by heterogeneous nucleation of new fibers on top of existing
ones (3,8,9). This mechanism explains many of the clinical
features of the disease (2,10), yet discrepancies between the
clinical facts and the predictions of the polymerization-
based scenario of the pathophysiology abound (11,12).
At the root of these discrepancies are features of the disease
that cannot be explained by the solubility and activity of
HbS, the only parameters in the double-nucleation mecha-
nism (4). It has been found that elevated levels of erythro-
cytes containing higher HbS concentrations, the so-called
dense cells, in which polymerization should be faster,
do not correlate with painful events, the main clinical mani-
festation of the disease (13). Although the rate of polymer-
ization in individual cells was found to scale with the
concentration of HbS in them (14), several studies have
shown that the clinical manifestations of sickle cell anemia
are dramatically different in patients with identical concen-
trations of HbS in their red blood cells (15–18). It was sug-
gested that these discrepancies point to the action of factors
for the disease severity, which are unrelated to HbS poly-
merization: erythrocyte adhesivity, endothelial activation,
platelet count, and others (12,19).
In this study, we test whether the presence of free heme in
supersaturated solutions of HbS may affect the rate of HbS
polymerization and in this way be another factor in theSubmitted June 2, 2010, and accepted for publication July 15, 2010.
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0006-3495/10/09/1976/10 $2.00disease pathophysiology. Heme may be released in sickle
erythrocytes after autoxidation of hemoglobin to methemo-
globin (20), but the presence of free heme in sickle cell
erythrocytes has seen controversy on several levels:
1. It has been argued that the reductive enzymes present in
the red cell cytosol would protect HbS from autoxidation
and in this way prevent the release of heme. The current
consensus appears to be that although normal red cells
are indeed protected, sickle red cells may succumb to
the stronger oxidative stress (21) due to chelated and
membrane-bound Fe3þ ions, oxygen radicals, and others,
found in them (22).
2. The propensity of HbS to autoxidize more avidly than
the normal adult hemoglobin, HbA, has been questioned.
A definitive study (21) showed that HbS has an exagger-
ated intrinsic oxidation rate compared with HbA. Of
greater importance, the same study found that the exog-
enous stimuli discussed in the previous paragraph, which
act at abnormal levels in sickle red cells, further enhance
HbS autoxidation.
3. Since the heme molecule is amphiphilic, with well-
defined charged and hydrophobic nonpolar parts, it has
been argued that it attaches to the phospholipid bilayer
of the red cell membrane or to the cytoskeleton, similar
to many other detergents (23,24). In fact, most detergents
are soluble in water as single molecules and their solu-
bility is several millimoles/liter (25). It is not surprising
that the heme solubility, determined below, is ~2 mM.
The heme solubility is the equilibrium concentration
for the exchange between heme in solution and in a solid
phase, which is likely to be crystalline and is called
hemozoin or b-hematin. The crystals consist of layers
of parallel porphyrin rings in hydrophobic contact with
one another, cross-linked by iron-oxygen and hydrogen
bonds (26,27). When embedded in the phospholipiddoi: 10.1016/j.bpj.2010.07.024
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with the lipid molecules, lacking the stronger iron-
oxygen and hydrogen bonds (28), and the free energy
of this interaction should be lower in magnitude than
that between heme molecules in the hemozoin crystal.
Hence, the equilibrium concentration of heme in contact
with a hydrophobic surface would be higher than the
solubility value above. Since the phospholipid bilayer
is a dynamic structure that constantly exchanges mole-
cules with the surrounding solution, arguments that the
heme may be permanently trapped by this layer so that
the heme concentration is kept lower than the equilib-
rium value are unfounded.
It appears that the controversial issues have been resolved
in favor of the presence of free heme in the red cell cytosol.
Correspondingly, free heme has been directly detected in
ghostless sickle hemolysate and its average concentration
in the tested samples was four or five times higher than in
normal red cells (29).
This free heme in the erythrocytes has been implicated
in damage of the red cell membrane, leading to higher red
cell adhesion to the endothelium (30). Existing evidence
suggests that higher frequency and severity of sickle cell
crises in patients with equal expression of HbS, such as
monozygotic twins, may be related to enhanced release of
heme, exhibited as membrane-bound iron (17).
The experiments discussed here illustrate another poten-
tial role of free heme in the pathophysiology of sickle cell
anemia: as a crucial cofactor of sickle cell hemoglobin poly-
merization. We show that removal of free heme completely
prevents polymerization and that its addition at micromolar
concentrations enhances the polymerization of sickle cell
hemoglobin by orders of magnitude. We propose a biophys-
ical mechanism of action of heme that explains the high effi-
cacy of heme at low concentrations.
Below, we test solutions with free heme completely
removed and with free heme concentration in the range
100–260 mM; for discussion of the methods employed, see
the Supporting Material. The chosen free heme concentra-
tions are 10–20 lower than the molar concentrations of
hemoglobin in the tested solutions. We show that these heme
concentrations are representative of the free heme present
during typical determinations of the rates of HbS polymer-
ization. The physiological relevance of the chosen heme
concentrations is more nuanced: although the results ob-
tained in the absence of heme may be relevant to in vivo
processes in some sickle cell patients, the concentrations
of the added heme are significantly higher than the average
free heme concentration in sickle red cells of <1 mM,
according to the single determination in Liu et al. (29).
However, although no determinations of the consistency
and steadiness of heme concentration in individual red cells
have been made, it is unlikely that the heme concentration
is uniform, equal to this average, and constant in timethroughout all red cells. Thus, our experiments may be
viewed as models of the HbS polymerization response to
spikes in intraerythrocytic heme concentration.RESULTS
Removal of the free heme from HbS solutions
Free heme may be present in the donated red blood cells
used as a source of HbS. However, since the HbS purifica-
tion procedures include ion exchange chromatography and
dialysis (31,32), no free heme is expected in freshly purified
HbS solutions. Indeed, the low amounts of free heme and
met-HbS in solutions prepared from freshly lysed red cells
were verified by the absorbance in the 600–650 nm range,
where absorbance of these two species was significantly
stronger than that of CO- or oxy-HbS (for details, see Galkin
et al. (31)). Hence, any free heme present in the HbS solu-
tions used in the studies of the polymerization kinetics
must have been released during storage, freezing, thawing,
and refreezing of the oxy-HbS stock, and during the
preparation of the CO-HbS solutions used in the kinetics
experiments.
To prepare a solution without this released heme, a solu-
tion sample was thawed, diluted with 0.15 M phosphate
buffer, and dialyzed overnight through a membrane with
a molecular mass (MM) cutoff of 2000 g mol
1. Thus,
during dialysis, the HbS was in oxy-state. The free heme,
which at near-neutral pH exists mostly as a dimer (33) for
which MM ¼ 1232 g mol1, is expected to dialyze out. To
slow any processes of HbS decay, such as autoxidation,
release of heme, denaturation, etc., during dialysis, it was
carried out at 3C. Since our method of characterization
of the polymerization kinetics uses CO-HbS, spectroscopic
characterization of the dialyzed HbS solutions was carried
out after conversion of HbS to this species and the addition
of sodium dithionite (see Methods). This characterization
showed that spectra of the dialyzed solutions were identical
to those of the undialyzed solution, and to the expected
spectra of CO-HbS (Fig. 1), except at l > 600 nm, as dis-
cussed below. The similarity of the spectra indicates that
in the undialyzed solutions, the amounts of both free
heme and apoglobin produced upon heme release are small
(for quantification, see below and Supporting Material).
It is possible that dialysis could affect solution pH, chlo-
ride, and 2,3-diphosphoglycerate (DPG) binding to HbS,
methemoglobin production, changes in the iron ligands,
and other factors. Changes of pH as a result of dialysis are
unlikely: the buffer against which dialysis is performed is
identical to the buffer in which HbS is dissolved. Since
during its purification by anion exchange chromatography
and dialysis HbS is in oxy-state, to which DPG binds weakly
(34,35), this allosteric effector of oxygen release is likely
not present in the solution at all. Since the chromatography
and dialysis media used during purification contain noBiophysical Journal 99(6) 1976–1985
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FIGURE 1 Spectra of HbS before and after dialysis through a membrane
with a 2000 g mol1 molecular mass cutoff are compared to a spectrum
calculated for a similar HbS concentration using data from Zjilstra et al.
(70). HbS was converted to a CO-state before spectrophotometry character-
ization, and 50 mM of sodium dithionite were added. Because of the low
HbS concentration, absorbance at wavelengths of l > 600 nm is low and
affected by noise.
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FIGURE 2 The concentration of free heme in solutions of HbS as a func-
tion of HbS concentration. Solid symbols represent determinations using
the cyanide method (see text and Supporting Material for details); open
symbols represent determinations using the dialysis method. The line is
a guide for the eye.
1978 Uzunova et al.chloride ions, it is likely that the purified HbS would be
stripped of any Cl– that might be bound to it in the red cells.
The lack of met-HbS production is evident from the simi-
larity of the solution spectra after different dialysis times,
from 12 to 24 h: production of met-hemoglobin would
have yielded increased absorbance in the wavelength range
600–650 nm (31). The suppression of met-HbS production
is likely due to the low temperature maintained during
dialysis. Since the solution contains only phosphate and
hydroxyl anions, which are in huge excess of the heme
iron cations both before and after dialysis, the liganded state
of the iron cation is likely preserved. Hence, we conclude
that none of the potential modifications of HbS molecules
listed above are likely during dialysis.
To test whether heme is indeed removed from the dia-
lyzed solution, we added albumin to the dialysis buffer:
heme binds to albumin, and the complex has a characteristic
peak at 404 nm (36–38). Evidence presented in the Sup-
porting Material demonstrates the removal of significant
amounts of heme from the HbS solutions.
As another test of the dialysis procedure, we varied the
length of dialysis from 12 to 24 h. Quantification of the
free heme removed from the solution by dialysis (see Sup-
porting Material for details) revealed that the concentration
of free heme found was independent of the dialysis length
within these limits. An important conclusion form this
observation is that the heme removed from the solution by
dialysis was not released during dialysis but was present
in the HbS solution before dialysis.Quantification of free heme concentration
in polymerizing HbS solutions
The absorption of light by heme and its derivatives in
aqueous solutions has not been extensively studied: the
measurements that exist were carried out mostly in organicBiophysical Journal 99(6) 1976–1985solvents or, if in aqueous solutions, used heme encapsulated
in detergent micelles (39). The spectra of heme in solutions
with compositions identical to that used in the quantification
of HbS polymerization kinetics (see Supporting Material)
are similar to those of met-Hb and indicate that the heme
iron is in Fe3þ form and heme is in the form of hemin. Since
the release of heme from the available met-HbS is partial,
and certain amounts of met-HbS remain in the solution,
direct spectroscopic determination of the heme concentra-
tion would be inaccurate. To detect free heme and quantify
its concentration in the presence of met-HbS, we employed
three methods: spectroscopy after dialysis, binding to albu-
min, and conversion of met-HbS to cyanmet-HbS. The
details and a discussion of the merits and errors of these
methods are provided in the Supporting Material.
Fig. 2 shows a summary of the determinations made using
the dialysis and cyanide methods, in which the concentra-
tion of free heme is plotted as a function of the HbS concen-
tration. The scatter in the free heme concentrations in Fig. 2
reflects an inherent error of the cyanide method of ~50%;
the two points determined after dialysis have lower errors.
With this caveat, the results of the two methods are consis-
tent. Fig. 2 indicates that the concentration of free heme
increases with higher HbS concentration. The ratio of the
free heme to HbS concentration is in the range 0.02–
0.04 mol heme/mole HbS. If we extrapolate this ratio to
the HbS concentrations used in the quantification of the
polymerization kinetics discussed below, 200–290 mg ml1
or 3–4.5 mM, we learn that the respective free heme concen-
trations would be in the range 120–180 mM.The effects of heme on HbS polymerization:
phenomenology
Fig. 3 shows a representative series of images that trace the
evolution of HbS polymerization in slides of controlled
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FIGURE 3 Effects of heme on the polymeriza-
tion of sickle cell hemoglobin. Solution of CO-HbS
is held in slides of uniform 5-mm thickness (32).
Photolysis by illumination with a wavelength of
532 nm in the center of the viewfield produces
deoxy-HbS, which polymerizes if its concentration
is above the solubility point (31,32). Each row
represents the evolution of polymerization under
a set of conditions. Time after start of photolysis
is indicated at each evolution step. HbS concentra-
tion and temperature are indicated for each row.
White arrows point to some of the HbS polymer
domains. (a) HbS polymerization in a solution
freshly prepared from stock stored under liquid
nitrogen for 1 week. (b) Removal of small mole-
cules by dialysis with a molecular mass cutoff of
2000 g mol1 prevents polymerization; increasing
temperature to 31C does not lead to polymeriza-
tion even though, as discussed in the text, higher
temperature enhances polymerization; HbS con-
centration is lower because of dilution during dial-
ysis. (c) After heme at the concentration shown is
added to another dialyzed solution sample, poly-
merization is extremely fast; the temperature was
lowered to slow down polymer nucleation and
growth so that nucleated polymers would be distin-
guishable.
TABLE 1 Summary of tested combinations of HbS
concentration and temperature of solutions for which there
was no polymerization after dialysis
HbS
concentration
(mg ml1) Temperature (C)
Duration of
exposure to
supersaturation (s)
q in
nondialyzed
solution (s)
280 24.7 77.4 1.5
27.7 77.4 0.7
237 22 77.4 8–38
30.9 77.4 6–33
31.0 128.7 6–33
36.5 129.9 5–28
235 33 129.9 4–27
35 129.9 3–22
36.5 129.9 2–18
Dialysis was performed through a membrane with 2000 g mol1 molecular
mass cutoff, and polymers did not appear after exposure to supersaturation
for extended times. For comparison, the nucleation delay times, q, from
Galkin and Vekilov (31) are shown in the last column. Since aging of
HbS solutions shortens q, ranges of this variable are shown where data
are available.
Free Heme and HbS Polymerization 1979thickness containing HbS solution (see Methods in the Sup-
porting Material). The images were taken with differential
interference contrast (DIC) microscopy, which allows detec-
tion of all HbS polymers nucleated in the illuminated area
(31,32). At each solution composition and temperature,
80–100 series of images were collected: each series started
with flash-photolysis of the CO-HbS to produce a supersatu-
rated solution of deoxy-HbS and ended after 70–120 images
were collected, which took up to 150 s. Although the exact
number of polymers existing at a given time in a series is
random, as expected for a stochastic process such as nucle-
ation (32,40), we chose series that represent the evolution of
the number of polymers averaged over ~100 repetitions, as
illustrated in Galkin and Vekilov (32).
In Fig. 3 a, the HbS solution is similar to that normally
used in HbS polymerization studies, i.e., without extra dial-
ysis after storage. We see that after starting with no poly-
mers, two polymers have formed at 18.2 s after initiation
of polymerization by photolysis, and approximately eight
at 20.8 s. Although this polymerization evolution is some-
what slower (see Supporting Material), it is close to the
typical behavior of HbS solutions at this temperature with
this concentration (31).
A surprising finding was that in the solutions dialyzed
after thawing of the stock, no polymers formed at 22C.
According to numerous experimental observations, higher
temperatures lead to faster polymerization (8,9,41). To com-
pensate for the solution dilution during dialysis, and to test
whether polymers might nucleate at higher temperature in
the absence of heme, the temperature was raised in three
steps (Table 1) to 36.5C. At each temperature, 20–50 seriesof images were collected. No polymerization occurred at
any of the temperature steps during any of the repetitions;
the lack of polymers at 31C is illustrated in Fig. 3 b. Table 1
provides a summary of all combinations of HbS concentra-
tion and temperature at which polymers appeared within
a few seconds, the so-called nucleation delay time, in
normally prepared HbS solutions, but did not appear for
extended periods in experiments repeated 20–50 times in
freshly dialyzed solutions. The lack of polymerization under
the conditions listed in the first row of Table 1—CHbS ¼
280 mg ml1, T ¼ 24.7C, and no heme—compared toBiophysical Journal 99(6) 1976–1985
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FIGURE 4 Effect of free heme on the nucleation rate, J (a), delay time, q
1980 Uzunova et al.the moderately fast polymerization at similar CHbS and
temperature in the presence of heme in Fig. 3 a demonstrates
unambiguously that it is the absence of heme, and not lower
concentration or different temperature, that leads to the
arrest of polymerization.
The addition of 260 mM of heme (this concentration is
comparable to, though somewhat higher than, the concentra-
tion predicted based on the heme/HbS ratio from Fig. 2) to
the dialyzed solution led to explosive polymerization at
22C. Since lower temperature leads to slower nucleation
and growth, the temperature was lowered to 9C, where
individual polymers could be distinguished. Because of
the higher solubility at this low temperature (3) and the
Arrhenius slowing of polymerization kinetics, one expects
significantly lower rates of nucleation and growth than in
Fig. 3 a. Yet the number of nucleated fibers and their dimen-
sions after ~20 s (Fig. 3 c) are about the same as in Fig. 3 a.
The observations in Fig. 3, a–c, show that free heme
accelerates HbS polymerization; in the absence of heme,
polymerization is prevented under the conditions tested
here and is likely significantly delayed in a broader range
of conditions.(b), and growth rate, R (c) in HbS polymer fibers. All determinations were
carried out as in previous studies (31,32). HbS concentrations (mg ml1)
are shown in a and b. Solid symbols represent HbS solution in 0.15 M phos-
phate buffer with no heme added. Open symbols represent dialyzed solu-
tions with heme added at the concentrations (mM) shown in b. Lines are
guides for the eye.Kinetics of nucleation and growth of HbS polymer
fibers in the presence of heme
Quantifications of the kinetics of nucleation and growth are
presented in Fig. 4. Since no HbS polymers nucleate after
dialysis through a membrane with a cutoff of 2000 g mol1,
J ¼ 0, q ¼ N, and R is undefined. The addition of micro-
molar concentrations of heme to dialyzed solutions yields
nucleation and growth rates that are significantly faster
and delay times that are shorter: For instance, in the pres-
ence of 260–280 mM heme, at CHbS ¼ 271 and 267 mg
ml1, values of J z 108 cm3 s1, q z 10–30 s, and
R z 0.2–0.6 mm s1 are achieved at temperatures lower
by 10–15C than those required for similar rates at
CHbS ¼ 265 mg ml1 without added heme. Since higher
temperature leads to faster polymerization (8,9,41), this
observation shows that heme significantly accelerates nucle-
ation and growth of HbS polymers. The slight concentration
difference in the experiments with and without specially
added free heme is insufficient to explain this significant
difference. To quantify the acceleration, we extrapolate
the data in Fig. 4, a–c, to temperature ranges where the rates
at different solution compositions can be compared (because
of the high sensitivity to temperature and concentration of
the kinetics of nucleation and growth, the ranges of J, q,
and R accessible by the methods used (31,32) limit direct
comparison). The good correspondence of the J(T), q(T),
and R(T) dependencies to the exponential function (Fig. 4)
(32,42,43) justifies such extrapolations. The comparison
reveals that the addition of heme enhances J by more than
two orders of magnitude and R by a factor of ~10 and
shortens q by approximately two orders of magnitude.Biophysical Journal 99(6) 1976–1985Note that the action of heme is different for J and q; which
is expected, since J and q are independent characteristics of
nucleation (42,44).Free heme and the precursors for HbS
polymer nuclei
In solutions of deoxy-HbS of concentration 67 mg ml1 and
higher, clusters of dense liquid exist; their size is ~300 nm
and it weakly depends on HbS concentration (45). Fig. 5 a
shows the fraction of the solution volume occupied by these
clusters, f2, determined by dynamic light scattering, as in
Pan et al. (45). Since the clusters are metastable (45), f2
is steady (the volume occupied by a stable new phase is
expected to increase in time). As HbS concentration, C,
is increased from 67 to 96 mg ml1, f2 increases from
~106 to ~105. Further increase of HbS concentration to
121, 131, and 178 mg ml1 (deoxy-HbS solubility at 22C
is 185 mg ml1 (3)) does not lead to increasing f2 (Fig. 5 b).
This behavior is in agreement with a recent theory of the
metastable dense liquid clusters in protein solutions (46).
According to this theory, clusters as large as several hundred
nanometers are kinetically stabilized by specific short-range
attraction between the molecules; for the significant role
played by short-range interactions in HbS polymerization,
see Vekilov et al. (43). This theory predicts cluster size
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FIGURE 5 The effect of free heme on the metastable dense liquid clus-
ters in deoxy-HbS solutions. Volume fraction, f2, occupied by clusters was
determined as in Pan et al. (45) at the five HbS concentrations shown in the
legend, and in the presence of heme at one of these concentrations. The
temperature was 22C. (a) Time dependence of the volume fraction at
five solution compositions, as indicated in the plot. (b) Dependence of
the average volume fraction from a on HbS concentration. The solid square
at 121 mg ml1 indicates the volume fraction in the presence of 66 mM of
free heme; open symbols indicate volume fraction in the absence of heme.
The line is a guide for the eye.
Free Heme and HbS Polymerization 1981weakly dependent on C, increasing f2 for relatively low C,
and f2 insensitive to C at intermediate C (46). From the
f2(C) dependence in Fig. 5 b, we conclude that the cluster
volume fraction complies with the predictions of this theory.
Hence, f2, which is ~10
5 at C ¼ 96–178 mg ml1, likely
has a similar value at 201 mg ml1 < C < 280 mg ml1,
the HbS concentration range in Fig. 4.
In the experiments depicted in Figs. 3 and 4, the volume
of the supersaturated HbS solution is ~108 cm3 (31). Since
the volume of one cluster is ~1013 cm3, with the above f2,
the solution contains about one cluster at steady state.
Since the fibers nucleate inside the clusters, this observation
indicates that cluster formation is the rate-determining step
in the nucleation of HbS polymers (see also Galkin et al.
(42)). The volume of an erythrocyte is ~100 smaller
than the test volume, so the probability of finding a cluster
in a red cell is low, and cluster formation may be the rate-
limiting step of nucleation of HbS polymers in vivo.
Fig. 5 shows that the addition of heme leads to an increase
in the cluster volume fraction, f2, by two orders of magni-
tude. The cluster radius is the same as in solutions without
heme, i.e., the cluster number density also increases by
two orders of magnitude. Since the nuclei of HbS fibers
form inside the metastable dense liquid clusters (42,47),the faster J and shorter q in Fig. 4 directly correlate to the
increase in f2.DISCUSSION
The mechanism of action of free heme
The above results show that micromolar amounts of free
heme lead to orders-of-magnitude acceleration of the nucle-
ation and growth of sickle cell polymers. To understand the
biophysical mechanisms by which such low heme con-
centrations cause significant acceleration of HbS polymeri-
zation, in a previous article (48), we characterized the
effects of heme on the intermolecular interactions in
hemoglobin solutions. We applied static light scattering
and differential refractometry to solutions of deoxy-HbS,
deoxy-HbA, and CO-HbA in the absence and presence of
free heme. The data reveal that in the presence of heme,
the attraction between the molecules of all three hemoglobin
variants is significantly stronger. Analyses based on the
Kirkwood-Goldberg theory of light scattering in three-
component systems (49) indicate that this attraction results
from a combination of electrostatic and hydrophobic behav-
iors and molecular dynamics: the negative heme molecules
electrostatically repel the negative hemoglobin molecules.
The repulsion by the heme excludes parts of the volume
for the hemoglobin molecules and induces effective attrac-
tion between them. The long-range nature of the electro-
static repulsion and the high mobility of the relatively
small heme, which allow a single heme molecule to interact
with many hemoglobin molecules, explain the high efficacy
of the heme.
An alternative explanation of heme effects on the kinetics
of polymerization is that their presence or absence affects
the conversion of CO-HbS to deoxy-HbS (similar to the
effects of DPG): CO-HbS does not polymerize and does
not partake in polymerization of deoxy-HbS in mixed
solutions. Hence, if the absence of heme leads to slower
or incomplete photolysis of CO-HbS, this could result
in slower, or potentially no, polymerization. Tests of the
heme effects on oxygen binding to hemoglobin were carried
out with HbA in the laboratory of R. Briehl at Albert
Einstein College of Medicine (R. Briehl, Albert Einstein
College of Medicine, Bronx, NY;personal communication,
2010). These preliminary control results showed that free
heme has no significant DPG-like effect on the oxyhemo-
globin dissociation curve. Although binding of oxygen to
HbA is different from binding of carbon monoxide to
HbS, it is still unlikely that heme may affect the binding
of CO to HbS to an extent sufficient to explain the dramatic
effects of free heme on HbS polymerization.
Thus, heme effects on nucleation and growth rate are
likely due to the effects of heme on interactions between
HbS molecules. To understand the acceleration of the nucle-
ation rate, we show in Fig. 5 that in HbS solutions, free hemeBiophysical Journal 99(6) 1976–1985
1982 Uzunova et al.enhances the volume fraction of the metastable dense liquid
clusters. Since the dense liquid clusters are where HbS poly-
mers nucleate, this increase is likely the cause of faster
nucleation of HbS polymers. In turn, the higher cluster
volume fraction is directly related to the enhanced attrac-
tion, which leads to lower excess free energy of the clusters
compared to the HbS solution.
To understand the acceleration of the growth rate in the
presence of heme, we note that Vekilov et al. (43) showed
that the hydration shell around the HbS molecules largely
determines their rate of attachment to the growing polymer
fiber. The action of heme on the growth rate likely occurs
through modification of this shell, discussed above and in
Pan et al. (48).
It is likely that in addition to its effects on the kinetics of
HbS polymerization, heme strongly affects the equilibrium
between the HbS polymers and the HbS solution. The
enhanced attraction between the HbS molecules in the pres-
ence of heme could lead to lower solubility; such correla-
tions between intermolecular attraction and solubility have
been recorded for many proteins (50,51) and theoretically
justified (52,53). With the lower solubility, heme-containing
HbS solutions would have higher supersaturation with
respect to the polymers than would solutions of equal HbS
concentration in the absence of heme. This scenario can
readily be tested by determining the solubility in the pres-
ence of heme and comparing it to data for solutions without
heme, e.g., those of Eaton and Hofrichter (3). The potential
heme effects on HbS solubility do not exclude, and likely
work in concert with, its kinetic effects on the rates of nucle-
ation and growth discussed above.Free heme and HbS polymerization in red cells
The results presented here show that the complete removal
of free heme leads to the arrest of HbS polymerization.
From this point of view, it appears that the observed pres-
ence of free heme in the red cell cytosol, even at its low
average concentration (29), is crucial for the known mild
sickling of large fractions of the red cells that occurs on
each passage through the venous circulation and does not
lead to vasoocclusive crises (54). The rates of nucleation
and growth of sickle cell polymers in the presence of such
low concentrations of heme are still to be tested at complete
deoxygenation and at physiological ranges of oxygen partial
pressure; however, it is likely that they are low. The low
rates may be the reason for the vast discrepancy between the
frequencies of deoxygenation of an erythrocyte (~1/min)
during which substantial numbers sickle and of vasoocclu-
sive crises of from once weekly to one to four per year
in severely sick patients. The likely nonuniformity of the
free heme concentration may be the reason why only
some of the red cells in the venous circulation of sickle-
cell patients undergo the mild sickling seen upon each
deoxygenation event (54).Biophysical Journal 99(6) 1976–1985Several explanations of the discrepancy between the sick-
ling and painful crisis frequencies have been proposed
(11,12,55). The strong effects of free heme on the nucleation
and growth of HbS polymers allow us to speculate that
a vasoocclusive crisis might also be triggered by a spike
in the intraerythrocyte free heme concentration due to
a failure of the antioxidative defense. Since a vasoocclusion
requires the coordinated catastrophic sickling (rigidification
and deformation) of many red blood cells (56), the spike in
free heme concentration should occur simultaneously in
numerous erythrocytes. Physiological factors that might
lead to concerted release of heme in numerous red blood
cells are discussed below.
In addition to the antioxidative defense system, the heme
concentration in the red cells is regulated by three removal
processes: diffusion through the cell membrane (28), associ-
ation to the membrane or the cytoskeleton (57), and intra-
cellular degradation by glutathione (22). The former two
mechanisms are concentration-dependent, and since the
heme concentration, even during the suspected spike, would
be below its solubility of 2 mM, excessive binding of heme
to the membranes is unlikely. The third mechanism requires
the availability of glutathione in the red blood cells at
concentrations up to 2 mM (58) and a fast rate of degrada-
tion reaction (22). Thus, if a spike in the concentration of
free heme occurs as a result of a failure of the antioxidative
defense, the removal processes may fail to wipe out the
heme excess.
As positive evidence for spikes in the free heme concen-
tration, one could consider the observation of free heme and
nonheme iron (produced by the degradation of heme by
glutathione (22)) in the red cell membranes (59,60), which
is unlikely if the concentration is fixed at 1 mM. Thus, the
higher severity of sickle cell anemia in one of the monozy-
gotic twins discussed in the Introduction and in Amin et al.
(17) might have been related to enhancement of catastrophic
sickling by the spikes of free heme concentration, evidenced
as membrane-bound iron.Possible external triggers of free heme
concentration spikes
Vasoocclusive crises in sickle cell anemia are precipitated
by many factors: hypoxia, acidosis, infection, and others;
often no specific cause is identified (61,62). The mechanism
of action of those factors can be related to polymeriza-
tion, endothelial activation, and vasoconstriction (61). The
extremely strong effects of relatively low concentrations
of free heme reported here suggest that these factors might
act also through formation of met-HbS with subsequent
heme release causing a spike in the free heme concentration.
A general mechanism for met-HbS formation is the
depletion of the reducing equivalents in the red cells and
increase of oxidant stress. Hypoxia appears to apply this
mechanism directly: at low-oxygen partial pressures, the
Free Heme and HbS Polymerization 1983autooxidation of hemoglobin is faster (33) and the produc-
tion of met-Hb is accelerated. This counterintuitive finding
has been attributed to the trapping of oxidative radicals
and ions by byproducts of the O2 molecule (33). The effects
of acidosis have been attributed to shifts of the oxygen
dissociation curve that favor deoxy-HbS formation. In addi-
tion to this, metabolic acidosis has been associated with,
among other factors, significant oxidative stress and
acquired methemoglobinemia (63), and this might be an
additional mechanism linking acidosis to sickle crises.
Vasoocclusion is often precipitated by infection. Many
mechanisms by which infection enhances sickling are dis-
cussed, including fever leading to dehydration, lack of
food intake leading to acidosis, and others (61). One should
keep in mind that the immune system response to most
viral and bacterial infections relies, to a large degree, on
the release of reactive oxygen species as a weapon against
foreign genetic material (64). Some infectious organisms
might produce reactive oxygen species on their own. Irre-
spective of its origin, the significant oxidative stress during
infection may lead to an increase in hemoglobin autoxida-
tion. Emotional stress results in adrenalin discharges, which
leads to vasoconstriction. However, adrenalin has a multi-
tude of effects, and a correlation between adrenaline and
reactive oxygen species production on the cellular level
has been established: adrenaline has been found to promote
hydroxyl radical generation in isolated rat hepatocytes (65).The variability of sickle cell anemia
and the effects of free heme
The vast variability of sickle cell anemia has been linked to
cellular, vascular, and phenotypic factors (11,12,19,66,67).
The strong effects of free heme discussed above suggest
that it might be another factor for this variability. It is likely
that the differences in the antioxidative defense system in
patients would lead to different responses to peak oxidative
stress and, hence, to stronger or weaker spikes of the free
heme concentration. Because of the high sensitivity of the
rates of nucleation and growth of sickle cell polymers to
the concentration of free heme, demonstrated in this article,
this variability could lead to significant variability in the
prognosis of patients with identical HbS expression. Thus,
the differences in antioxidative defense of different patients
may emerge as a new factor (in addition to differences in
red-cell adhesion, endothelial activation, platelet count,
and others) in the vast variability of clinical outcome of
sickle cell anemia (67).
A more significant suggestion emerging from our results
is that if the resistance of the red cell cytosol to spikes in free
heme concentration in the erythrocytes is enhanced, this
might result in milder sickling and less severe sickle cell
symptoms. Thus, the regulation of free heme concentration
spikes might be an alternative route in the search for sickle
cell anemia treatments. Such regulation might be achievedby enhancement of heme degradation, e.g., by glutathione,
or of the reductive pathways that prevent formation of
met-HbS.
The larger field of fundamental research of the patho-
physiology of sickle cell is largely focused on the search
for genetic modifiers of the behavior of the cells in the
microcirculation (18,66,67). The results presented here on
the effects of the heme on sickle cell hemoglobin polymer-
ization suggest that some of the genes identified as modifiers
of sickle cell severity might act through regulation of the
amount of free heme in the erythrocytes: by suppressing
HbS autoxidation or by enhancing heme degradation.The link between sickle cell disease and malaria
Last, it is possible that the heme released in red blood cells
infected by malaria plasmodia as a byproduct of the para-
sites’ metabolism of hemoglobin (68) causes the known
sickling of sickle-trait erythrocytes (which would not sickle
in the absence of heme because of lower HbS activity) and
enables their selective removal from the circulation (69).
This may be a novel explanation of the link between malaria
and sickle cell disease.SUPPORTING MATERIAL
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